Form 4: Luxfer Holdings CFO Exercises Stock Options and Sells Shares in Pre-Arranged Transaction
Insider Transaction Report
Luxfer Holdings PLC's Chief Financial Officer, Stephen Webster, exercised a significant number of stock options and dividend equivalent rights, subsequently selling a portion of the acquired shares, as disclosed in a recent SEC Form 4 filing.
Summary
- Stephen Webster, the Chief Financial Officer of Luxfer Holdings PLC (LXFR), engaged in multiple transactions involving the company's Ordinary Shares on June 9, 2025.
- Mr. Webster acquired a total of 8,384 Ordinary Shares through the exercise of various time-based and performance-based stock options, as well as dividend equivalent rights.
- The exercised options included 800 shares from time-based options awarded on March 15, 2021, and 128 related dividend equivalent rights.
- Further acquisitions included 1,000 shares from time-based options awarded on March 14, 2022, and 125 related dividend equivalent rights.
- Performance-based options awarded on March 14, 2022, also vested and were exercised, including 2,304 shares based on achieving Earnings Per Share (EPS) Growth goals and 900 shares based on achieving Total Shareholder Return (TSR) goals for the three-year period ended December 31, 2024.
- Additional time-based options exercised included 1,070 shares awarded on March 20, 2023, with 92 related dividend equivalent rights, and 1,790 shares awarded on March 18, 2024, with 75 related dividend equivalent rights.
- Following these acquisitions, Mr. Webster disposed of 4,244 Ordinary Shares at a price of $11.83 per share.
- The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
- After all reported transactions, Mr. Webster directly beneficially owns 26,662 Ordinary Shares.
- Mr. Webster retains unexercised stock options and dividend equivalent rights that will vest in future installments, including 1,000 options vesting on March 14, 2026; 2,140 options vesting in two equal annual installments from March 20, 2026; and 5,370 options vesting in three equal annual installments from March 18, 2026, along with their respective dividend equivalent rights.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. While there is a sale of shares, it's part of a pre-arranged plan (10b5-1) and follows the successful vesting of both time-based and performance-based options, indicating the company met its financial and shareholder return targets. The exercise of options by a key executive generally reflects confidence.
Positives
- The successful vesting of performance-based stock options indicates that Luxfer Holdings PLC achieved its Earnings Per Share (EPS) Growth and Total Shareholder Return (TSR) goals for the three-year performance period ended December 31, 2024.
- The exercise of a significant number of stock options by the CFO demonstrates continued engagement and potential confidence in the company's long-term prospects, as these are often long-term incentive awards.
- The transaction was conducted under a Rule 10b5-1(c) plan, which suggests a pre-scheduled and non-discretionary sale, often used for personal financial planning or tax purposes, rather than a reaction to new negative information.
Negatives
- The disposition of 4,244 Ordinary Shares by the Chief Financial Officer represents a reduction in his direct ownership of the company's stock, which could be perceived negatively by some investors, although it is common for executives to sell shares to cover taxes or for diversification after option exercises.
Future Outlook
The document indicates future vesting schedules for remaining stock options held by the CFO, with installments beginning in March 2026 for options awarded in 2022, 2023, and 2024, suggesting continued long-term incentive alignment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions and does not provide broader industry context. However, the achievement of EPS Growth and TSR goals for performance-based options suggests that Luxfer Holdings PLC has met internal financial and shareholder return targets, which could be indicative of a healthy operational performance within its specific industry segment.
Stakeholder Impact
- Shareholders: The exercise of performance-based options indicates the company met its EPS Growth and TSR goals, which is generally positive for shareholder value. The sale of shares by the CFO is a routine insider transaction, often for tax or diversification purposes, and may not necessarily signal a negative outlook.
- Employees: The vesting of stock options, particularly performance-based ones, can serve as a positive signal regarding the company's performance and the effectiveness of its incentive programs for employees.
Next Steps
- Remaining stock options awarded on March 14, 2022, are scheduled to vest on March 14, 2026.
- Remaining stock options awarded on March 20, 2023, will vest in two equal annual installments beginning on March 20, 2026.
- Remaining stock options awarded on March 18, 2024, will vest in three equal annual installments beginning on March 18, 2026.
Key Dates
| Date | Description |
|---|---|
| 2021-03-15 | Award date for time-based Stock Options, 800 of which were exercised. |
| 2022-03-14 | Award date for time-based Stock Options (1,000 exercised) and performance-based Stock Options (2,304 and 900 exercised). |
| 2023-03-20 | Award date for time-based Stock Options, 1,070 of which were exercised. |
| 2024-03-18 | Award date for time-based Stock Options, 1,790 of which were exercised. |
| 2024-12-31 | End of the three-year performance period for EPS Growth and TSR goals related to performance-based Stock Options. |
| 2025-03-14 | Vesting and exercisability date for certain time-based and performance-based Stock Options awarded on March 14, 2022. |
| 2025-03-15 | Vesting and exercisability date for certain time-based Stock Options awarded on March 15, 2021. |
| 2025-03-18 | Vesting and exercisability date for certain time-based Stock Options awarded on March 18, 2024. |
| 2025-03-20 | Vesting and exercisability date for certain time-based Stock Options awarded on March 20, 2023. |
| 2025-06-09 | Date of the reported transactions (exercise of options and sale of shares). |
| 2025-06-11 | Date the Form 4 was signed. |
| 2026-03-14 | Vesting date for remaining Stock Options awarded on March 14, 2022. |
| 2026-03-18 | Beginning of three equal annual installments for vesting of remaining Stock Options awarded on March 18, 2024. |
| 2026-03-20 | Beginning of two equal annual installments for vesting of remaining Stock Options awarded on March 20, 2023. |
| 2027-03-15 | Expiration date for Stock Options awarded on March 15, 2021. |
| 2027-03-14 | Expiration date for performance-based Stock Options awarded on March 14, 2022. |
| 2028-03-14 | Expiration date for time-based Stock Options awarded on March 14, 2022. |
| 2029-03-20 | Expiration date for Stock Options awarded on March 20, 2023. |
| 2030-03-18 | Expiration date for Stock Options awarded on March 18, 2024. |
Keywords
Luxfer Holdings PLC, LXFR, SEC Form 4, Insider Trading, Stock Options, Share Disposition, CFO, Stephen Webster, Equity Compensation, Rule 10b5-1, Performance-Based Options, Time-Based Options, Dividend Equivalent Rights, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.